| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 26 buys and 17 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.88M | - | |
| 10% | 32.0K | $910.6K | - | |
| VP | 19.0K | $540.4K | -16,558 | |
| CEO | 14.8K | $421.1K | - | |
| Other | 13.1K | $372.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2020 | Davis Stephen68 | CEO | Sale+OE | 200,000 | $46.02 | $9,204,691.76 | -35.9% | |
| May 11, 2020 | Daly James M | Director | Sale+OE | 26,250 | $51.13 | $1,342,178.25 | -100% | |
| Apr 30, 2020 | Kim Austin D.66 | EVP &General Counsel | Sale+OE | 1,072 | $49.22 | $52,763.84 | -30.5% | |
| Apr 30, 2020 | Yang Michael J. | EVP And CCO | Sale+OE | 1,501 | $49.21 | $73,864.21 | -22.4% | |
| Apr 30, 2020 | Davis Stephen68 | CEO | Sale+OE | 6,770 | $49.21 | $333,151.70 | -36.4% | |
| Apr 30, 2020 | Ridloff Elena48 | EVP And CFO | Sale+OE | 11,050 | $50.59 | $559,034.00 | -83.4% | |
| Apr 30, 2020 | Stankovic Srdjan R.62 | President | Sale+OE | 4,308 | $49.21 | $211,996.68 | -27.5% | |
| Apr 23, 2020 | Stankovic Srdjan R.62 | President | Sale+OE | 18,949 | $50.07 | $948,729.06 | -75.9% | |
| Apr 22, 2020 | Stankovic Srdjan R.62 | President | Sale+OE | 154,019 | $50.11 | $7,717,356.14 | -92.7% | |
| Mar 18, 2020 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 1,050,000 | $32.05 | $33,652,025.54 | +0.2% |